Literature DB >> 9221955

Effects of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide in the rat kindling model of epilepsy.

Y Wada1, J Shiraishi, M Nakamura, Y Koshino.   

Abstract

This study assessed the action of the serotonin3 (5-HT3) receptor agonist, 1-(m-chlorophenyl)-biguanide (m-CPBG), against both kindled seizures and kindling development from the rat amygdala (AM). The intracerebroventricular (i.c.v.) administration of 40 microg m-CPBG significantly increased the duration of afterdischarge and bilateral forelimb clonus of generalized kindled seizures. In addition, daily i.c.v. treatment with m-CPBG at the same dose prior to each electrical stimulation to the AM significantly facilitated behavioral and electrographic seizure development and reduced the number of stimulations needed to elicit generalized seizures. The present results indicate that m-CPBG increases the duration of fully kindled seizures and facilitates the developmental seizure process, suggesting an excitatory role of 5-HT3 receptors in the kindling model of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9221955     DOI: 10.1016/s0006-8993(97)00366-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Effect of ramosetron, a 5-HT3 receptor antagonist on the severity of seizures and memory impairment in electrical amygdala kindled rats.

Authors:  Zeynab Sayahi; Alireza Komaki; Masoud Saidi Jam; Seyed Asaad Karimi; Safoura Raoufi; Parastoo Mardani; Marzieh Naderishahab; Abdolrahman Sarihi; Javad Mirnajafi-Zadeh
Journal:  J Physiol Sci       Date:  2022-01-16       Impact factor: 2.781

Review 2.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

3.  Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2-2q11.2.

Authors:  Lyndal Henden; Saskia Freytag; Zaid Afawi; Sara Baldassari; Samuel F Berkovic; Francesca Bisulli; Laura Canafoglia; Giorgio Casari; Douglas Ewan Crompton; Christel Depienne; Jozef Gecz; Renzo Guerrini; Ingo Helbig; Edouard Hirsch; Boris Keren; Karl Martin Klein; Pierre Labauge; Eric LeGuern; Laura Licchetta; Davide Mei; Caroline Nava; Tommaso Pippucci; Gabrielle Rudolf; Ingrid Eileen Scheffer; Pasquale Striano; Paolo Tinuper; Federico Zara; Mark Corbett; Melanie Bahlo
Journal:  Hum Genet       Date:  2016-07-01       Impact factor: 4.132

4.  Does Serotonin Play a Role in Epilepsy?

Authors:  William H. Theodore
Journal:  Epilepsy Curr       Date:  2003-09       Impact factor: 7.500

5.  Serotonin neurones have anti-convulsant effects and reduce seizure-induced mortality.

Authors:  Gordon F Buchanan; Nicholas M Murray; Michael A Hajek; George B Richerson
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

6.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

Review 7.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

Review 8.  5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy.

Authors:  Hongyan Zhao; Yang Lin; Shurui Chen; Xin Li; Hongliang Huo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells.

Authors:  Ki Jung Kim; Seung Hyun Jeun; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

10.  Seizure developed after palonosetron intravenous injection during recovery from general anesthesia -A case report-.

Authors:  Pyung-Gul Park; Hwa-Yong Shin; Hyun Kang; Yong Hun Jung; Young-Cheol Woo; Jin-Yun Kim; Gill Hoi Koo; Sun Gyoo Park; Chong Wha Baek
Journal:  Korean J Anesthesiol       Date:  2012-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.